20 Publikationen in 2023
Kumulativer IF: 208.3
Mittelwert IF: 10.42

1. Reperfusion Injury: How Can We Reduce It by Pre-, Per-, and Postconditioning.
Buske M, Desch S, Heusch G, Rassaf T, Eitel I, Thiele H, Feistritzer HJ
J Clin Med; 13:159    (Impact Factor = 3,9)

2. Differences in vasomotor function of mesenteric arteries between Ossabaw minipigs with predisposition to metabolic syndrome and Göttingen minipigs.
Eickelmann C, Lieder HR, Sturek M, Heusch G, Kleinbongard P
Am J Physiol Heart Circ Physiol; 10.1152/ajpheart.00719.2023    (Impact Factor = 4,8)

3. Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
Heusch G, Andreadou I, Bell R, Bertero E, Botker HE, Davidson SM, Downey JM, Eaton P, Ferdinandy P, Gersh BJ, Giacca M, Hausenloy DJ, Ibanez B, Krieg T,Maack C, Schulz R, Sellke F, Shah AM, Thiele H, Yellon DM, Di Lisa F
Redox Biol; doi: 10.1016/j.redox.2023.102894    (Impact Factor = 11,4)

4. Improving rigor and reproducibility in cardiovascular research.
Lindsey ML, LeBlanc AJ, Bertrand L, Bradshaw AD, Kleinbongard P
Am J Physiol Heart Circ Physiol; 325:H866-H868.    (Impact Factor = 4,8)

5. Perspective: mitochondrial STAT3 in cardioprotection.
Kleinbongard P
Basic Res Cardiol; 18:32    (Impact Factor = 9,5)

6. Cardioprotection in cardio-oncology: a case for concern?
Heusch G
Cardiovasc Res; doi: 10.1093/cvr/cvad111    (Impact Factor = 10,8)

7. No robust reduction of infarct size and no-reflow by metoprolol pretreatment in adult Göttingen minipigs
Kleinbongard P, Lieder HR, Skyschally A, Heusch G
Basic Res Cardiol; 23    (Impact Factor = 9,5)

8. Cardioprotection and its Translation: A Need for New Paradigms? Or for New Pragmatism? An Opinionated Retro- and Perspective
Heusch G
J Cardiovasc Pharmacol Ther; 28: doi:10.1177/10742484231179613    (Impact Factor = 2.6)

9. Mitochondrial respiration analysis in permeabilized porcine left ventricular and human right atrial specimens with ischemia/reperfusion
Eickelmann C, Lieder HR, Shehada S-E, Thielmann M, Heusch G, Kleinbongard P
Am J Physiol Heart Circ Physiol; Online ahead of print    (Impact Factor = 4,8)

10. Attenuation of ST-segment elevation by ischemic preconditioning: Reflection of cardioprotection in Göttingen but not in Ossabaw minipigs
Lieder HR, Adam V, Skyschally A, Sturek M, Kleinbongard P, Heusch G
Int J Cardiol; doi: 10.1016/j.ijcard.2023.05.026    (Impact Factor = 3,5)

11. Diazoxide is a powerful cardioprotectant, but not feasible in a realistic infarct scenario
Kleinbongard P, Lieder H, Skyschally A, Heusch G
Front Cardiovasc Med; 10 doi: 10.3389/fcvm.2023.1173462    (Impact Factor = 3,6)

12. Spring cleaning: freshening up the portfolio
Lindsey ML, Kassiri Z, LeBlanc AJ, Ripplinger CM, Kirk JA, Carter JR, Kleinbongard P, Brunt KR
Am J Physiol Heart Circ Physiol; 324:H840-H842    (Impact Factor = 4,8)

13. Primordial non-responsiveness: a neglected obstacle to cardioprotection
Heusch G, Bøtker HE, Ferdinandy P, Schulz R
Eur Heart J; 44:1687–1689    (Impact Factor = 39,3)

14. We asked and you answered.
Lindsey ML, Kleinbongard P, Kassiri Z, Carter JR, Hansell Keehan K, Ripplinger CM, LeBlanc AJ, Brunt KR, Kirk JA
Am J Physiol Heart Circ Physiol; 324:H657-H658    (Impact Factor = 4,8)

15. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
Ferdinandy P, Andreadou I, Baxter GF, Bøtker HE, Davidson SM, Dobrev D, Gersh BJ, Heusch G, Lecour S, Ruiz-Meana M, Zuurbier CJ, Hausenloy DJ, Schulz R
Pharmacol Rev; 75:159-216    (Impact Factor = 21,1)

16. Sex still matters in cardiovascular research.
Lindsey ML, Carter JR, Ripplinger CM, Kassiri Z, Hansell Keehan K, Brunt KR, Kirk JA, Kleinbongard P, LeBlanc AJ
Am J Physiol Heart Circ Physiol.; 324:H79-H81    (Impact Factor = 4,8)

17. Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases.
yöngyösi M, Alcaide P, Asselbergs FW, Brundel BJJM, Camici GG, Martins PDC, Ferdinandy P, Fontana M, Girao H, Gnecchi M, Gollmann-Tepeköylü C, Kleinbongard P, Krieg T, Madonna R, Paillard M, Pantazis A, Perrino C, Pesce M, Schiattarella GG, Sluijter JPG, Steffens S, Tschöpe C, Van Linthout S, Davidson SM.
Cardiovasc Res; 119:336-356    (Impact Factor = 10,8)

18. Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor
Lieder HR, Tsoumani M, Andreadou I, Schrör K, Heusch G, Kleinbongard P
Cardiovasc Drugs Ther; 37:865-876    (Impact Factor = 3,4)

19. Coronary interventions 2021: insights from the National Societies of Cardiology Journals of the European Society of Cardiology
Monsuez JJ, Gatzov P, Ferreira-Gonzalez I, Alfonso F
Eur Heart J; 44:251-253    (Impact Factor = 39,3)

20. No sex-related differences in infarct size, no-reflow, and protection by ischaemic pre-conditioning in Göttingen minipigs
Kleinbongard P, Lieder HR, Skyschally A, Heusch G
Cardiovasc Res; 119:561-570    (Impact Factor = 10,8)